<DOC>
	<DOC>NCT01857609</DOC>
	<brief_summary>This study aims to investigate the effect of proton pump inhibitor on the pharmacokinetics and pharmacodynamics of metformin in healthy Korean men.</brief_summary>
	<brief_title>Clinical Trial to Investigate the Effect of Proton Pump Inhibitor on the Pharmacokinetics and Pharmacodynamics of Metformin</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>healthy male subject aged 20 to 45 at screening A body weight in the range of 50 kg (inclusive) 100 kg (inclusive) with ideal body weight range of + 25% subjects who decide to participate voluntarily and write a informed consent form subjects who have clinically significant disease of cardiovascular, respiratory, renal, endocrinological, hematological, gastrointestinal, neurological(central nervous system), psychiatric disorders or malignant tumor Subject judged not eligible for study participation by investigator.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Metformin</keyword>
	<keyword>Proton pump inhibitor</keyword>
	<keyword>Drug interaction</keyword>
</DOC>